MedicalResearch.com Interview with:
Anna Gundlund, MD, PhD
Herlev-Gentofte Hospital, Department of Cardiology
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Atrial fibrillation increases a person’s risk of ischemic strokes up to 5-fold. Oral anticoagulation therapy lowers this risk effectively (>60%) and is therefore recommended for patients with atrial fibrillation and at least 1-2 other risk factors for stroke.
Our study show, that oral anticoagulation therapy is still underused in patients with atrial fibrillation – even after a stroke event. In stroke survivors with atrial fibrillation, oral anticoagulation therapy were associated with better outcomes than no oral anticoagulation therapy.
MedicalResearch.com: What should readers take away from your report?
Response: Oral anticoagulation therapy is effective (and safe) as secondary stroke prophylaxis in patients with atrial fibrillation.
MedicalResearch.com: What recommendations do you have for future research as a result of this work?
Response: Treatment rates with oral anticoagulation therapy have increased over time and we should keep on being aware that this tendency continues.
Gundlund A, Xian Y, Peterson ED, et al. Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial FibrillationResults From a Nationwide Cohort. JAMA Network Open. 2018;1(1):e180171. doi:10.1001/jamanetworkopen.2018.0171
The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.